Cytek Biosciences reported revenue of $48.14M and net income of -$12.16M for the quarter ended Jun 2026, up 5.6% year over year. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||
| Revenue | 34.38M | 38.89M | 35.06M | 40.16M | 40.48M | 48.34M | 37.09M | 49.69M | 48.00M | 58.23M | 44.86M | 46.62M | 51.50M | 57.48M | 41.46M | 45.60M | 52.29M | 62.14M | 44.13M | 48.14M | |||||
| Cost of RevenueCost of Rev | 13.10M | 15.26M | 14.89M | 15.60M | 13.62M | 18.96M | 16.05M | 21.53M | 20.82M | 25.18M | 21.85M | 21.18M | 22.50M | 23.82M | 21.30M | 21.73M | 24.74M | 29.26M | 22.88M | 19.80M | |||||
| Gross Profit | 21.28M | 23.64M | 20.18M | 24.56M | 26.86M | 29.37M | 21.04M | 28.16M | 27.18M | 33.05M | 23.01M | 25.44M | 29.00M | 33.65M | 20.16M | 23.87M | 27.55M | 32.88M | 21.25M | 28.34M | |||||
| Operating items | |||||||||||||||||||||||||
| Research & DevelopmentR&D | 6.55M | 7.34M | 8.03M | 8.44M | 8.81M | 9.75M | 11.14M | 14.37M | 12.08M | 11.56M | 12.54M | 12.27M | 12.43M | 11.87M | 12.51M | 12.13M | 11.67M | 13.13M | 11.65M | 13.17M | |||||
| Selling, General & AdministrativeSG&A | 5.75M | 6.94M | 7.55M | 8.59M | 8.04M | 10.51M | 12.08M | 10.79M | 10.35M | 10.76M | 11.41M | 11.69M | 10.94M | 9.07M | 12.90M | 13.53M | 16.12M | 16.39M | 18.47M | 16.82M | |||||
| Other Operating ExpensesOther Opex | 6.08M | 8.04M | 6.96M | 8.43M | 8.65M | 9.03M | 9.97M | 12.14M | 11.17M | 10.87M | 9.80M | 10.00M | 9.88M | 9.72M | 9.72M | 8.83M | 8.96M | 8.96M | 9.60M | 9.74M | |||||
| Operating ExpensesOpex | 18.38M | 22.32M | 22.53M | 25.45M | 25.50M | 29.29M | 33.20M | 37.29M | 33.60M | 33.19M | 33.75M | 33.96M | 33.25M | 30.67M | 35.13M | 34.49M | 36.74M | 38.48M | 39.72M | 39.74M | |||||
| Operating IncomeOp. Inc | 2.90M | 1.32M | -2.36M | -0.89M | 1.36M | 0.08M | -12.16M | -9.13M | -6.42M | -0.14M | -10.73M | -8.53M | -4.25M | 2.99M | -14.97M | -10.62M | -9.19M | -5.59M | -18.46M | -11.40M | |||||
| EBIT | 2.90M | 1.32M | -2.36M | -0.89M | 1.36M | 0.08M | -12.16M | -9.13M | -6.42M | -0.14M | -10.73M | -8.53M | -4.25M | 2.99M | -14.97M | -10.62M | -9.19M | -5.59M | -18.46M | -11.40M | |||||
| Non-operating items | |||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.44M | 0.49M | 0.59M | 0.65M | 0.65M | 0.69M | 0.67M | 0.41M | 0.59M | 0.39M | 0.44M | 0.13M | 0.12M | -5.93M | 0.29M | 0.41M | 0.49M | -0.72M | 0.26M | 0.28M | |||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.02M | 0.15M | -0.19M | 0.01M | -0.00M | -0.04M | -0.02M | 0.20M | -0.05M | -0.07M | -0.03M | 0.12M | 0.04M | -0.20M | -0.15M | ||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.02M | 0.02M | 0.39M | 1.58M | 2.63M | 2.14M | 1.20M | 1.62M | 1.45M | 1.36M | 1.42M | 1.43M | 0.91M | 0.51M | 0.56M | 0.57M | 0.58M | 0.79M | 0.82M | |||||
| Other Non Operating IncomeOther Non Op Inc. | -0.39M | -0.40M | -0.37M | -0.25M | -0.45M | 2.09M | 1.65M | 1.74M | 1.21M | 3.19M | 0.82M | 0.06M | 3.09M | 0.49M | 3.49M | 3.71M | 1.34M | 0.26M | 0.56M | -0.78M | |||||
| Non Operating IncomeNon Op. Inc. | -0.82M | -0.87M | -0.95M | -0.51M | 0.49M | 4.03M | 3.12M | 2.53M | 2.23M | 4.25M | 1.74M | 1.34M | 4.41M | 7.34M | 3.71M | 3.85M | 1.42M | 1.56M | 1.09M | -0.24M | |||||
| Net income details | |||||||||||||||||||||||||
| EBT | 2.08M | 0.44M | -3.30M | -1.40M | 1.85M | 4.11M | -9.04M | -6.59M | -4.18M | 4.11M | -8.99M | -7.19M | 0.16M | 10.32M | -11.27M | -6.78M | -7.77M | -4.03M | -17.37M | -11.64M | |||||
| Tax ProvisionsTaxes | 0.66M | 1.61M | -1.15M | -0.70M | 0.22M | 0.40M | -2.23M | -2.21M | 2.30M | -1.36M | -2.82M | 3.25M | -0.80M | 0.72M | 0.14M | -1.20M | -2.30M | 40.05M | 1.50M | 0.52M | |||||
| Profit After TaxPAT | 1.42M | -0.33M | -3.58M | -1.36M | 1.67M | 5.24M | -6.81M | -5.56M | -6.46M | 5.81M | -6.17M | -10.43M | 1.24M | 9.64M | -11.40M | -5.58M | -5.48M | -44.08M | -18.87M | -12.16M | |||||
| Income from Non-Controlling InterestsInc. Minority | 0.03M | -0.14M | 0.10M | -0.04M | 0.19M | -0.23M | 0.23M | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 1.42M | -1.17M | -2.16M | -0.70M | 1.63M | 3.72M | -6.81M | -4.39M | -6.49M | 5.47M | -6.17M | -10.43M | 0.96M | 9.60M | -11.40M | -5.58M | -5.47M | -44.08M | -18.87M | -12.16M | |||||
| Consolidated Net IncomeConsol Net Inc. | 1.42M | -1.17M | -2.16M | -0.70M | 1.63M | 3.72M | -6.81M | -4.39M | -6.49M | 5.47M | -6.17M | -10.43M | 0.96M | 9.60M | -11.40M | -5.58M | -5.47M | -44.08M | -18.87M | -12.16M | |||||
| Income towards Parent CompanyParent Net Inc | 1.42M | -1.17M | -2.16M | -0.70M | 1.63M | 3.72M | -6.81M | -4.39M | -6.49M | 5.47M | -6.17M | -10.43M | 0.96M | 9.60M | -11.40M | -5.58M | -5.47M | -44.08M | -18.87M | -12.16M | |||||
| Preferred Dividend PaymentsPref Dividends | 1.07M | -1.19M | |||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | 0.35M | -2.02M | -0.60M | 1.67M | 3.53M | -6.81M | -4.39M | -6.46M | 5.50M | -6.17M | -10.43M | 0.94M | 9.64M | -11.40M | -5.58M | -5.48M | -44.08M | -18.87M | -12.16M | ||||||
| Additional items | |||||||||||||||||||||||||
| EPS (Basic) | 0.00 | -0.02 | 0.00 | 0.01 | 0.03 | -0.05 | -0.03 | -0.05 | 0.04 | -0.05 | -0.08 | 0.01 | 0.07 | -0.09 | -0.04 | -0.04 | -0.35 | -0.15 | -0.09 | ||||||
| EPS (Diluted) | 0.00 | -0.02 | 0.00 | 0.01 | 0.03 | -0.05 | -0.03 | -0.05 | 0.04 | -0.05 | -0.08 | 0.01 | 0.07 | -0.09 | -0.04 | -0.04 | -0.35 | -0.15 | -0.09 | ||||||
| Shares Outstanding | 108.32M | 76.74M | 133.90M | 134.40M | 134.71M | 134.51M | 135.49M | 135.92M | 136.17M | 135.28M | 130.92M | 131.44M | 131.00M | 130.61M | 128.34M | 126.93M | 127.55M | 127.75M | 128.70M | 129.46M | |||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 113.64M | 81.54M | 133.90M | 134.40M | 138.71M | 138.56M | 135.49M | 135.92M | 136.17M | 135.28M | 130.92M | 131.44M | 132.79M | 130.61M | 128.34M | 126.93M | 127.55M | 127.75M | 128.70M | 129.46M | |||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 108.32M | 76.74M | 134.24M | 134.60M | 134.85M | 135.37M | 135.64M | 136.34M | 135.55M | 130.71M | 131.25M | 131.51M | 129.77M | 129.21M | 127.60M | 127.19M | 127.86M | 128.55M | 129.14M | 129.98M | |||||
| EBITDA | 2.90M | 1.32M | -2.36M | -0.89M | 1.36M | 0.08M | -12.16M | -9.13M | -6.42M | -0.14M | -10.73M | -8.53M | -4.25M | 2.99M | -14.97M | -10.62M | -9.19M | -5.59M | -18.46M | -11.40M | |||||
| Interest ExpensesInt Expense | 0.44M | 0.49M | 0.59M | 0.65M | 0.65M | 0.69M | 0.67M | 0.41M | 0.59M | 0.39M | 0.44M | 0.13M | 0.12M | -5.93M | 0.29M | 0.41M | 0.49M | -0.72M | 0.26M | 0.28M | |||||
| Tax Rate | 31.57% | 362.39% | 34.67% | 49.89% | 12.11% | 9.63% | 24.70% | 33.46% | -54.96% | -33.11% | 31.40% | -45.20% | -509.55% | 6.97% | -1.21% | 17.71% | 29.60% | -993.43% | -8.63% | -4.42% |